28 related articles for article (PubMed ID: 34121230)
1. Prognostic value of tumour-infiltrating CD8+ lymphocytes in rectal cancer after neoadjuvant chemoradiation: is indoleamine-2,3-dioxygenase (IDO1) a friend or foe?
Schollbach J; Kircher S; Wiegering A; Seyfried F; Klein I; Rosenwald A; Germer CT; Löb S
Cancer Immunol Immunother; 2019 Apr; 68(4):563-575. PubMed ID: 30671614
[TBL] [Abstract][Full Text] [Related]
2. Tumour budding as a prognostic biomarker in biopsies and resections of neoadjuvant-treated rectal adenocarcinoma.
Aherne S; Donnelly M; Ryan ÉJ; Davey MG; Creavin B; McGrath E; McCarthy A; Geraghty R; Gibbons D; Nagtegaal I; Lugli A; Kirsch R; Martin ST; Winter DC; Sheahan K;
Histopathology; 2024 Apr; ():. PubMed ID: 38629323
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of T lymphocyte subgroups (CD4 and CD8) in lung cancer patients after neoadjuvant chemotherapy.
Elicora A; Yaprak Bayrak B; Vural C; Sezer HF; Uzun Erkal S; Metin E
J Cardiothorac Surg; 2024 Mar; 19(1):113. PubMed ID: 38468248
[TBL] [Abstract][Full Text] [Related]
4. The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy - results from the AGITG DOCTOR trial and the cancer evolution biobank.
Lonie JM; Brosda S; Bonazzi VF; Aoude LG; Patel K; Brown I; Sharma S; Lampe G; Addala V; Koufariotis LT; Wood S; Waddell N; Dolcetti R; Barbour AP
Front Immunol; 2023; 14():1220129. PubMed ID: 37965317
[TBL] [Abstract][Full Text] [Related]
5. Spatial transcriptomic analysis reveals local effects of intratumoral fusobacterial infection on DNA damage and immune signaling in rectal cancer.
Duggan WP; Kisakol B; Woods I; Azimi M; Dussmann H; Fay J; O'Grady T; Maguire B; Reynolds IS; Salvucci M; Slade DJ; McNamara DA; Burke JP; Prehn JHM
Gut Microbes; 2024; 16(1):2350149. PubMed ID: 38709233
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of tumor budding in rectal cancer after neoadjuvant therapy: a systematic review and meta-analysis.
Li J; Ma Y; Wen L; Zhang G; Huang C; Wang J; Yao X
Syst Rev; 2024 Jan; 13(1):22. PubMed ID: 38191437
[TBL] [Abstract][Full Text] [Related]
7. Effects of tumour budding on adjuvant chemotherapy in colorectal cancer.
Xie H; Zeng Z; Hou Y; Ye F; Cai T; Cai Y; Xiong L; Li W; Liu Z; Liang Z; Luo S; Zheng X; Huang L; Liu H; Kang L
BJS Open; 2024 Jan; 8(1):. PubMed ID: 38190579
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological Significances and Prognostic Role of Intratumoral Budding in Colorectal Cancers.
Kang G; Pyo JS; Kim NY; Kang DW
J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233405
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral Budding in Pretreatment Biopsies, among Tumor Microenvironmental Components, Can Predict Prognosis and Neoadjuvant Therapy Response in Colorectal Adenocarcinoma.
Yim K; Jang WM; Cho U; Sun S; Chong Y; Seo KJ
Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888645
[No Abstract] [Full Text] [Related]
10. High CD8
Koemans WJ; van Dieren JM; van den Berg JG; Meijer GA; Snaebjornsson P; Chalabi M; Lecot F; Riedl R; Krijgsman O; Hofland I; Broeks A; Voncken FEM; Peppelenbosch MP; Sosef MN; van Sandick JW; Kodach LL
Histopathology; 2021 Aug; 79(2):238-251. PubMed ID: 33660299
[TBL] [Abstract][Full Text] [Related]
11. IMMUNOREACT 0: Biopsy-based immune biomarkers as predictors of response to neoadjuvant therapy for rectal cancer-A systematic review and meta-analysis.
Stepanyan A; Fassan M; Spolverato G; Castagliuolo I; Scarpa M; Scarpa M;
Cancer Med; 2023 Sep; 12(17):17878-17890. PubMed ID: 37537787
[TBL] [Abstract][Full Text] [Related]
12. Immune response in colorectal carcinoma: a review of its significance as a predictive and prognostic biomarker.
Bell PD; Pai RK
Histopathology; 2022 Dec; 81(6):696-714. PubMed ID: 35758208
[TBL] [Abstract][Full Text] [Related]
13. Combined histopathological risk score using TP53 protein expression, CD8
Chen W; Farchoukh L; Seigh L; Hartman DJ; Pai RK
Histopathology; 2021 Nov; 79(5):826-835. PubMed ID: 34121230
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral budding and automated CD8-positive T-cell density in pretreatment biopsies can predict response to neoadjuvant therapy in rectal adenocarcinoma.
Farchoukh L; Hartman DJ; Ma C; Celebrezze J; Medich D; Bahary N; Frank M; Pantanowitz L; Pai RK
Mod Pathol; 2021 Jan; 34(1):171-183. PubMed ID: 32661298
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral Budding and CD8-Positive T-cell Density in Pretreatment Biopsies as a Predictor of Response to Neoadjuvant Chemoradiotherapy in Advanced Rectal Cancer.
Sano S; Akiyoshi T; Yamamoto N; Hiyoshi Y; Mukai T; Yamaguchi T; Nagasaki T; Taketomi A; Fukunaga Y; Kawachi H
Clin Colorectal Cancer; 2023 Dec; 22(4):411-420.e1. PubMed ID: 37516615
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]